Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
Company Directory
AdvanDx
10A Roessler Road
Woburn
MA 01801
USA
[t] 001 339 227 4052
AdvanDx is a leading provider of advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections.

AdvanDx's easy-to-use products provide fast and accurate results that enable improvements in patient care and help to save lives and reduce hospital costs.

AdvanDx's products employ standard laboratory techniques and equipment to reduce startup, implementation, technician and maintenance time, while providing fast results without sacrificing accuracy. Major medical centers, reference labs, government institutions and community hospitals throughout the USA, Europe and Asia rely on AdvanDx products as integral parts of their medical care.
AdvanDx unveils rapid pathogen tests
16 March, 2012
AdvanDx plans to unveil the company's new QuickFISH rapid pathogen tests at the European Congress for Clinical Microbiology and Infectious Diseases in London, United Kingdom (March 31st to April 3rd).
AdvanDx receives FDA 510(k) clearance for GNR Traffic Light PNA FISH test
18 January, 2011
AdvanDx receives FDA 510(k) clearance for the company’s GNR Traffic Light PNA FISH test which is the first test capable of simultaneously identifying Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa directly from positive blood cultures containing Gram-negative rods in less than 90 minutes.
AdvanDx launches GNR Traffic Light PNA FISH test in Europe
13 August, 2010
AdvanDx launches its CE-IVD marked GNR Traffic Light PNA FISH test in Europe which is the first-ever test capable of simultaneously identifying Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa directly from positive blood cultures in less than 90 minutes.
Yeast Traffic Light PNA FISH test receives FDA 510(k) clearance
30 July, 2010
AdvanDx receives FDA 510(k) clearance for a fast, 90 minutes protocol for its Yeast Traffic Light PNA FISH test.
AdvanDx offers PBP2a MRSA test to US patients
25 May, 2010
AdvanDx is now offering the BinaxNOW PBP2a test from Inverness Medical Innovations to customers in the USA.
AdvanDx receives FDA 510(k) clearance PNA FISH tests protocol
22 December, 2009
AdvanDx receives FDA 510(k) clearance for a fast, 90 minutes protocol for its E coli/P aeruginosa PNA FISH and EK/P aeruginosa PNA FISH tests.
AdvanDx releases fast protocol for PNA FISH tests in Europe
29 April, 2009
AdvanDx launches a fast, 90 minute protocol for all CE-IVD marked PNA FISH tests in Europe.
Mercy Integrated Labs uses PNA FISH tests to identify bloodstream pathogens quickly
18 March, 2009
Mercy Integrated Labs in Toledo, Ohio, USA is implementing AdvanDx's PNA FISH tests to identify bloodstream pathogens one to three days earlier than conventional methods to help physicians, pharmacists and nurses at hospitals served by the lab to improve care and outcomes for patients with bloodstream infections (Ref 1).
Medical study shows AdvanDx's PNA FISH test reduces mortality rates
23 October, 2008
AdvanDx has announced that a new medical study demonstrated the use of AdvanDx's PNA FISH test reduced mortality by 42 percent for patients with highly drug resistant Hospital-Acquired Enterococcus faecium bloodstream infections (BSIs).
Study shows effectiveness of AdvanDx's PNA FISH test to combat bloodstream infections
16 July, 2008
AdvanDx has announced that a new study shows use of AdvanDx's PNA FISH test was associated with an 82 percent reduction in mortality rates from S aureus bloodstream infections in the intensive care unit (ICU), a 53 percent reduction in overall mortality from staphylococcal bloodstream infections, and a significant reduction in antibiotic use.
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo